期刊文献+

乳腺良、恶性病变组织中人乳头瘤病毒检测和分型 被引量:4

Detection and typing of human papillomaviruses in breast benign and malignant lesions
暂未订购
导出
摘要 目的:研究乳腺良、恶性病变组织中人乳头瘤病毒(HPVs)感染情况。方法:收集新鲜乳癌组织标本73例和乳腺良性病变组织标本84例,采用PCR方法对乳腺良、恶性病变组织中HPVs进行检测和分型。结果:73例乳癌组织中,HPV16阳性率为76.7%(56/73),高危型HPVs(HPV16和59)总阳性率76.7%(56/73);其中HPV16单独感染20例,HPV16、59混合感染6例,HPV16、6/11混和感染28例,3者混和感染2例。84例乳腺良性病变组织中,HPV16阳性率为48.8%(41/84),高危型HPVs总阳性率为51.2%(43/84);其中HPV16单独感染15例,HPV59单独感染2例,HPV6/11单独感染2例,HPV16、6/11混和感染24例,3者混和感染2例。乳腺良、恶性病变组织中均未检测到HPV18、31、33、52和58。乳癌组织中HPV16阳性率和高危型HPVs总阳性率高于乳腺良性病变(χ2分别为12.879,10.921,P<0.01)。浸润性导管癌组织中HPV16阳性率为86.0%(43/50),高于浸润性小叶癌组织中的56.6%(13/23)(χ2=7.663,P<0.01)。结论:HPV16在乳癌发生发展中可能具有重要作用,与乳癌组织学类型有关;其与其他HPVs亚型的混合感染值得重视。 Aim:To investigate the infection rate and typing of human papillomaviruses(HPVs) in breast benign and malignant lesions.Methods:A total of 73 fresh breast carcinoma tissue and 84 fresh breast benign lesions were collected and subjected to detect and type HPVs by PCR assay.Results:In 73 breast carcinoma tissue,the positive rate of HPV16 was 76.7%(56/73),that of high risk-HPVs(HPV16 and 59) was 76.7%(56/73),including 20 cases with HPV16 infection alone,6 cases with HPV16 and 59 mixed infection,28 cases with HPV16 and 6/11 mixed infection, and 2 cases with multiple infection (HPV16 with HPV59 and HPV6/11 ). In 84 breast benign lesions, the positive rate of HPV16 was 48.8% (41/84) , that of high risk-HPVs was 51.2% (43/84) ,including 15 cases with HPV16 infection alone,2 cases with HPV59 infection alone ,2 cases with HPV6/11 infection alone ,24 cases with HPV16 and 6/11 mixed infection, 2 cases with multiple infections (HPVI6 with HPV59 and HPV6/11 ). HPV18,31,33,52, and 58 were not found in all breast benign and malignant lesions. There was significant difference in the positive rates of HPV16 and HR-HPVs between breast benign and malignant lesions (χ^2 was 12. 879,10. 921 ,respectively,P 〈0.01 ). The positive rate of HPV16 in invasive ductal carcinoma tissue was 80.6% (43/50) , higher than 56.6% ( 13/23 ) in invasive lobular carcinoma tissue (χ^2 = 7. 663, P 〈 0.01 ). Conclusion :HPV16 may play an important role in the carcinogenesis of breast carcinoma, and the mixed infection of HPV16 with HPV59 or HPV6/11 should be emphasized in breast carcinoma.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2009年第4期713-717,共5页 Journal of Zhengzhou University(Medical Sciences)
基金 卫生部科研基金资助项目WKJ2007-2-022 河南省高校杰出科研人才创新工程基金资助项目2007KYCX013
关键词 人乳头瘤病毒 乳癌 乳腺良性病变 human papillomavirus breast carcinoma breast benign lesion
  • 相关文献

参考文献15

  • 1Chakrabarti O, Krishna S. Molecular interactions of "high risk" human papillomaviruses E6 and E7 oncoproteins: impli- cations for turnout progression [ J ]. J Biosci ,2003,28 (3) :337.
  • 2Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application[J]. Nat Rev Cancer,2002,2(5):342.
  • 3Lo KW, Wang YF, Chan MK,et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China [ J ]. Int J Cancer,2002,100 ( 3 ) : 327.
  • 4Gillison ML, D'Souza G, factor profiles for human and human papillomavirus Westra W, et al. Distinct risk papillomavirus type 16-positive type 16-negative head and neck cancers [J]. J Natl Cancer Inst,2008,100(6) :407.
  • 5朱林忠,苏秀兰,陈克能,杨仁杰,邢海平,崔建国,柯杨.人乳头状瘤病毒16在食管癌不同人群中的检出率[J].癌症,2005,24(7):870-873. 被引量:21
  • 6Cheng YW, Wu MF, Wang J, et al. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation [ J ]. Cancer Res, 2007,67 (22) :10 686.
  • 7Massimi P, Thomas M, Bouvard V, et al. Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer [ J ]. Virology, 2008,371 (2) :374.
  • 8Li T, Lu ZM, Guo M, et al. p53 codon 72 polymorphism (C/G) and the, risk of human papillomavirus-associated carcinomas in China[J]. Cancer,2002,95(12):2 571.
  • 9Hussain SK, Sundquist J, Hemminiki K. Familial clustering of cancer at human papillomavirus-associated sites according to the Swedish Family-Cancer Database[ J]. Int J Cancer, 2008,122(8) :1 873.
  • 10Lawson JS, Ganzburg WH, Whitaker NJ. Viruses and human breast cancer[ J]. Future Microbiol, 2006,1:33.

二级参考文献5

共引文献20

同被引文献29

  • 1Brown C, Knwalczyk AM, Taylor ER, et al. P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein[ J]. Virol J,2008,5:5.
  • 2Chakrabarti O, Krishna S. Molecular interactions of "high risk" human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression [ J ]. J Biosci, 2003, 28(3) :337.
  • 3Zur Hausen H. Papillomaviruses and cancer from basic studies to clinical application[ J]. Nat Rev Cancer,2002,2 (5) :342.
  • 4Stoler MH. Human papillomavirus and cervical neoplasia: a model for carcinogenesis [ J ]. Int J Gynecol Pathol,2000, 19(1) :16.
  • 5Chen L, Ashe S, Singhal MC, et al. Metastatic conversion of cells by expression of human papillomavirus type 16 E6 and E7 genes[J]. Proc Natl Acad Sci, USA,1993,90(14) :6 523.
  • 6Wiest T, Schwarz E, Enders C, et al. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control[ J]. Oncogene, 2002,21 (10) :1 510.
  • 7Yasmeen A,Bismar TA,Kandouz M,et al.E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells.Cell Cycle,2007,6(16):2038-2042.
  • 8Akil N,Yasmeen A,Kassab A,et al.high-risk human papillomavims infections in breast cancer in syrian women and their association with Id-1 expression:a tissue microarray study.Br J Cancer,2008,99(3):404-407.
  • 9de León DC,Monfiel DP,Nemcova J,et al.Human papillomavirus (HPV) in breast tumors:prevalence in a group of Mexican patients.BMC Cancer,2009,9:26.
  • 10Xiangwei Li, Lei Gao, Huijun Li, et el. Human papillomavirus in- fection and laryngeal cancer risk : A systematic review and meta- a- nalysis[ J]. J Infectious Dis,2013,207( 1 ) :479 -488.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部